Abstract: The present disclosure provides a composition comprising theobromine and a rice bran and germ extract comprising glycosphingolipids, which at particular weight ratios has surprising beneficial characteristics that finds use in skin care applications, particularly to inhibit visible signs of skin aging.
Claims:1. A composition comprising:
a. theobromine; and
b. a mixture comprising;
i. cyclodextrin;
ii. rice extract; and
iii. glycosphingolipids,
wherein cyclodextrin weight concentration in said mixture is in the range of 55-65%, rice extract weight concentration in said mixture is in the range of 35-40%, and glycosphingolipids weight concentration in said mixture is in the range of 1-5%.
2. The composition as claimed in claim 1, wherein said mixture is a hexane and ethanol extract of rice bran and rice germ.
3. The composition as claimed in claim 1, wherein glycosphingolipids weight concentration in said mixture is in the range of 2-4%.
4. The composition as claimed in claim 1, wherein theobromine to mixture w/w ratio in said composition is in the range of 1:1-1:5.
5. The composition as claimed in claim 2, wherein theobromine to mixture w/w ratio in said composition is in the range of 1:2-1:4.
6. The composition as claimed in claim 3, wherein theobromine to mixture w/w ratio in said composition is 1:2.5.
7. The composition as claimed in claim 5, further comprises suitable carriers, diluents, and excipients.
8. A method of inhibiting skin aging, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-7; and
b. contacting said composition with skin,
wherein said method inhibits skin aging.
9. The method as claimed in claim 8, wherein said method inhibits appearance of wrinkles, fine lines, and loss of skin elasticity.
10. A method of preparing a composition as claimed in any of the claims 1-7.
11. A composition as claimed in any of the claims 1-7 for use in preparing topical formulations for inhibiting skin aging.
, Description:As Attached
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [18-01-2016(online)].pdf | 2016-01-18 |
| 2 | Form 3 [18-01-2016(online)].pdf | 2016-01-18 |
| 3 | Drawing [18-01-2016(online)].pdf | 2016-01-18 |
| 4 | Description(Complete) [18-01-2016(online)].pdf | 2016-01-18 |
| 5 | 201641001820-Power of Attorney-230316.pdf | 2016-04-04 |
| 6 | 201641001820-Form 1-230316.pdf | 2016-04-04 |
| 7 | 201641001820-Correspondence-230316.pdf | 2016-04-04 |
| 8 | 201641001820-FORM 18 [03-12-2019(online)].pdf | 2019-12-03 |
| 9 | 201641001820-FER.pdf | 2020-07-29 |
| 1 | ORYZACERAMIDEsearchE_21-07-2020.pdf |
| 2 | 2020-07-2015-31-43E_21-07-2020.pdf |